Discover the latest innovations in prostate cancer screening, treatment options, and the importance of patient engagement. Stay informed and empowered in the fight against prostate cancer!
Prostate cancer remains a significant health concern, sparking debates on screening methods. Traditional approaches using PSA levels have been crucial, but new guidelines advocate for early screenings, especially for Black men as young as 40. The Australian TheraP trial highlighted promising results in treating metastatic castration-resistant prostate cancer, offering hope for improved outcomes. Pfizer Oncology's efforts in advancing prostate cancer treatment underscore the importance of leveraging scientific advancements.
When it comes to prostate cancer treatment, understanding the side effects of different options is vital for informed decision-making. A new resource aims to enhance patients' comprehension of treatments, with a focus on improving survival rates. Patient empowerment through education and engagement is key, as highlighted by initiatives like the prostate cancer report card, which boosts patients' involvement in treatment decisions.
In a study of 8,513 South Australian men with localized prostate cancer, real-life data paved the way for a comprehensive understanding of treatment options. This valuable resource equips patients with accessible information crucial for navigating their prostate cancer journey effectively.
Prostate cancer screening: while blood tests measuring prostate-specific antigen (PSA) levels have been a primary screening tool.
New prostate screening guidelines organized by the Prostate Cancer Foundation aim to address the longstanding health disparity in prostate cancer: Black men ...
As reported in The Lancet Oncology by Michael S. Hofman, MBBS, and colleagues, the Australian phase II TheraP trial has shown similar overall survival with ...
By Matthew Cotter, PhD, Vice President, Global Medical Affairs, Prostate Cancer, Pfizer Oncology Sponsored by Pfizer Inc.
Understanding the pros and cons of different treatments may help men and their health care teams make more informed treatment decisions. Doctor showing ...
Every week, more than 400 men are diagnosed with prostate cancer. With treatment, survival rates for prostate cancer are high, but understanding the ...
The more informed the patients are, the more likely they are to participate in decision makingโฆPatient engagement in decisions reduces decisional regret and ...
The report is based on real-life data from 8,513 South Australian men diagnosed with localized prostate cancer. It provides clear, accessible information to ...